ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2014 to Q1 2020

Type / Class
Debt / NOTE 3.000%12/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2020 Q1 $0 $0 -$185 0
2019 Q4 $3 $185 -$125,259,815 6166.67% 1
2019 Q3 $115,574,000 $125,260,000 -$2,464,851 107.9% 17
2019 Q2 $116,646,000 $141,316,000 +$18,328,813 121.13% 20
2019 Q1 $101,935,985 $112,569,691 +$7,748,921 109.85% 22
2018 Q4 $95,525,000 $107,136,000 -$26,165,489 100.0% 21
2018 Q3 $122,970,000 $130,857,564 +$36,384,656 105.91% 22
2018 Q2 $87,894,704 $99,578,821 +$22,612,529 113.3% 20
2018 Q1 $68,347,334 $74,835,447 -$8,583,420 109.53% 24
2017 Q4 $68,098,836 $78,815,178 +$8,554,973 115.21% 24
2017 Q3 $60,709,047 $65,906,798 +$3,192,019 108.5% 17
2017 Q2 $57,788,683 $60,888,015 -$16,507,476 105.45% 22
2017 Q1 $73,369,512 $77,711,438 -$16,451,182 106.0% 21
2016 Q4 $88,830,482 $102,604,553 +$4,140,832 115.22% 21
2016 Q3 $78,812,692 $172,027,237 +$2,646,808 123.22% 19
2016 Q2 $68,463,453 $74,046,410 -$4,775,084 108.12% 23
2016 Q1 $74,572,353 $66,642,519 -$4,602,298 89.43% 22
2015 Q4 $76,239,118 $74,558,825 -$5,676,119 97.67% 19
2015 Q3 $90,289,542 $83,806,298 -$21,351,372 92.52% 22
2015 Q2 $106,054,284 $121,191,692 -$14,444,016 114.01% 21
2015 Q1 $118,688,750 $136,295,579 -$16,472,973 115.0% 19
2014 Q4 $127,882,000 $134,255,000 +$121,311,000 105.06% 19